Navigation Links
SeprOx Receives Texas Emerging Technology Fund Award
Date:6/11/2009

THE WOODLANDS, Texas, June 11 /PRNewswire/ -- SeprOx Corporation received a pre-seed commercialization award from the Texas Emerging Technology Fund (ETF) presented by Governor Rick Perry at Texas Technology Leadership Day held this past Friday at the Houston Technology Center. SeprOx will receive an initial investment of $250,000 and is eligible to receive up to $1 million in total funding.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090611/DA30680LOGO)

"Too often, great ideas are shelved with no clear path to the marketplace when grants run out or new projects are started, when they could improve people's lives. The Emerging Technology Fund is our solution to that problem," Gov. Perry said. "The ETF is super-charging the research environment in our state, harnessing our people's amazing ideas, and encouraging even greater efforts to inquire, innovate and invest."

Established by Gov. Perry and the Texas Legislature in 2005, the ETF is bringing the best scientists and researchers to Texas, attracting high-paying jobs, and helping start-up companies get off the ground faster. The ETF program has been renewed to fund awards through August 2011.

"In spite of these uncertain economic times, it is exciting to see more companies from the Houston region commercializing breakthrough technology, solving real human problems, creating good jobs and building the region's and the state's reputation as a 21st century technology hub," said Walter Ulrich, president and CEO, Houston Technology Center.

"We are extremely appreciative of this vote of confidence by the Governor and the State of Texas and look forward to commercializing a product that will have a positive impact on the health and well-being of the people of Texas," commented Dr. Robert Schucker, CEO of SeprOx.

About SeprOx Corporation

SeprOx Corporation, located in The Woodlands, TX, was established in 2008 as a wholly owned subsidiary of Trans Ionics Corporation (TIC) to scale up and commercialize groundbreaking technology capable of separating virtually pure oxygen from air using a proprietary membrane material under exclusive license from the Texas Center for Superconductivity's Energy Materials Program at the University of Houston. Applications of the technology range from small medical oxygen generators to large industrial oxygen systems for clean coal combustion and gasification. The Company expects to complete fabrication of a working prototype of its five liter per minute portable medical oxygen generator for patients that have chronic obstructive pulmonary disease within twelve months. For more information, visit www.seprox.com.

About Houston Technology Center

Houston Technology Center (HTC), a business accelerator and the largest technology business incubator in Texas, accelerates the commercialization of emerging technology companies in the Greater Houston area. A 501(C)(3)non-profit organization, HTC assists Houston-based entrepreneurs within several key sectors: Energy, Information Technology, Life Sciences, Nanotechnology and NASA/Aerospace technologies, by providing in-depth business guidance, access to capital and service providers, and entrepreneurial education. For more information, visit www.houstontech.org.


'/>"/>
SOURCE SeprOx Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SHPS Receives Re-Accreditation from URAC for Multiple Health Management Programs
2. Herley Receives a $1.2 Million Contract Award for Complex Integrated Microwave Assemblies for U.S. Electronic Attack Aircraft
3. Elder Care Expert Doctor Marion Receives Accolades from Lehman College, Mature Market Resource Center in Same Week
4. Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
5. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
6. MedApps Receives FDA Clearance on a New Way to Bring Cost-Effective Remote Health Monitoring to More People
7. Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
8. Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
9. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
10. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
11. Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: